First-Line Antihypertensive Medications and Dosages
For most adults with hypertension, initiate treatment with a thiazide-type diuretic, specifically chlorthalidone 12.5-25 mg daily, as it has the strongest evidence for reducing cardiovascular events and mortality. 1, 2
Initial Drug Selection by Stage
Stage 1 Hypertension (130-139/80-89 mmHg)
- Start with a single antihypertensive agent and titrate upward before adding additional medications 1
- The preferred first-line agent is a thiazide-type diuretic 3, 1
Stage 2 Hypertension (≥140/90 mmHg or ≥160/100 mmHg)
- Initiate with two first-line agents of different classes, either as separate prescriptions or as a fixed-dose combination 1, 4
- For blood pressure ≥20/10 mmHg above goal, strongly consider starting dual therapy immediately 3
First-Line Medication Classes and Dosages
Thiazide and Thiazide-Like Diuretics (Preferred)
Chlorthalidone (strongest evidence):
- Initial dose: 12.5-25 mg once daily 2
- Maximum dose: 50-100 mg once daily 2
- Superior to hydrochlorothiazide for blood pressure reduction, particularly at night, with longer half-life 3
- Proven superior to lisinopril for stroke prevention and to amlodipine for heart failure prevention 1, 5
Hydrochlorothiazide:
- Initial dose: 12.5-25 mg once daily 3
- Maximum dose: 50 mg once daily 3
- Less potent than chlorthalidone but acceptable alternative when chlorthalidone unavailable 3, 5
ACE Inhibitors
Lisinopril:
- Initial dose: 10 mg once daily 6
- Usual range: 20-40 mg once daily 6
- Maximum dose: 80 mg once daily 6
- For patients on diuretics, start with 5 mg once daily 6
Angiotensin Receptor Blockers (ARBs)
Losartan:
- Initial dose: 50 mg once daily 7
- Maximum dose: 100 mg once daily 7
- For volume-depleted patients (e.g., on diuretics), start with 25 mg once daily 7
Calcium Channel Blockers
Amlodipine:
Special Population Considerations
Black Patients Without CKD or Heart Failure
- Initiate with thiazide diuretic or calcium channel blocker as first-line therapy 1
- ACE inhibitors are less effective than thiazides and calcium channel blockers for stroke and heart failure prevention in this population 1
Patients with Diabetes and Albuminuria
- Start with ACE inhibitor or ARB to reduce progressive kidney disease risk 1, 4
- Monitor serum creatinine, eGFR, and potassium within 7-14 days after initiation 1, 4
Patients with Coronary Artery Disease
- ACE inhibitors or ARBs are preferred first-line agents 4
Patients with Chronic Kidney Disease and Albuminuria (UACR ≥30 mg/g)
- ACE inhibitors or ARBs strongly recommended 4
Pediatric Patients (≥6 years)
- Lisinopril: 0.07 mg/kg once daily (up to 5 mg), maximum 0.61 mg/kg (up to 40 mg) once daily 3
- Losartan: 0.7 mg/kg once daily (up to 50 mg), maximum 1.4 mg/kg (up to 100 mg) once daily 7
Critical Pitfalls to Avoid
Medication Selection Errors
- Do not use beta-blockers as first-line therapy for uncomplicated hypertension—they are less effective, particularly for stroke prevention in older adults 1, 4
- Do not use alpha-blockers as first-line therapy—they are inferior to other agents for cardiovascular disease prevention 1
- Never combine ACE inhibitors with ARBs—this increases adverse events without additional benefit 4
Monitoring Failures
- Always monitor potassium and renal function within 7-14 days after starting ACE inhibitors, ARBs, or diuretics 1, 4
- Continue monitoring at least annually thereafter 4
- Thiazide diuretics can cause hypokalemia; maintain potassium >3.5 mmol/L to avoid increased ventricular ectopy 3
Dosing Errors
- Avoid high-dose thiazide diuretics—use low doses (chlorthalidone 12.5-25 mg, hydrochlorothiazide 12.5-25 mg) to minimize metabolic side effects while maintaining efficacy 3, 2
- For patients with hepatic impairment, start losartan at 25 mg once daily 7
- For patients with low systolic blood pressure (100-120 mmHg), start lisinopril at 2.5-5 mg once daily 6
Pregnancy Considerations
- ACE inhibitors, ARBs, and mineralocorticoid receptor antagonists are contraindicated in pregnancy and should be avoided in women of childbearing potential without reliable contraception 4
Practical Treatment Algorithm
- Assess for compelling indications (diabetes with albuminuria, CKD, CAD, heart failure) 1, 4
- If compelling indications present: Use indicated agent (ACE inhibitor/ARB for diabetes with albuminuria, CKD with albuminuria, or CAD) 1, 4
- If no compelling indications and non-Black: Start chlorthalidone 12.5-25 mg daily 1, 2
- If no compelling indications and Black: Start chlorthalidone 12.5-25 mg daily or calcium channel blocker 1
- Titrate to maximum tolerated dose before adding second agent 1
- If blood pressure remains uncontrolled: Add second agent from different class (ACE inhibitor/ARB, calcium channel blocker, or additional thiazide if not already using) 3, 1